Cargando…

Regenerative therapy for spinal cord injury using iPSC technology

Spinal cord injury (SCI) is a devastating event that causes permanent neurologic impairments. Cell transplantation therapy using neural precursor cells (NPCs) is a promising intervention aiming to replace damaged neural tissue and restore certain functions. Because the protocol to produce human indu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagoshi, Narihito, Okano, Hideyuki, Nakamura, Masaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565344/ https://www.ncbi.nlm.nih.gov/pubmed/33088363 http://dx.doi.org/10.1186/s41232-020-00149-0

Ejemplares similares

A review of regenerative therapy for spinal cord injury using human iPS cells
por: Kawai, Momotaro, et al.
Publicado: (2022)

Regenerative medicine strategies for chronic complete spinal cord injury
por: Hashimoto, Shogo, et al.
Publicado: (2023)

Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells
por: Kajikawa, Keita, et al.
Publicado: (2020)

Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury
por: Okubo, Toshiki, et al.
Publicado: (2018)

Mechanisms of Stem Cell Therapy in Spinal Cord Injuries
por: Shinozaki, Munehisa, et al.
Publicado: (2021)

LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury
por: Ito, Shuhei, et al.
Publicado: (2021)

Cell therapy for spinal cord injury using induced pluripotent stem cells
por: Nagoshi, Narihito, et al.
Publicado: (2019)

Rehabilitative Training Enhances Therapeutic Effect of Human iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury
por: Shibata, Takahiro, et al.
Publicado: (2023)

Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury
por: Kitagawa, Takahiro, et al.
Publicado: (2022)

A Narrative Review of Advances in Neural Precursor Cell Transplantation Therapies for Spinal Cord Injury
por: Kitagawa, Takahiro, et al.
Publicado: (2022)

First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol
por: Sugai, Keiko, et al.
Publicado: (2021)

Hepatocyte growth factor pretreatment boosts functional recovery after spinal cord injury through human iPSC-derived neural stem/progenitor cell transplantation
por: Suematsu, Yu, et al.
Publicado: (2023)

iPSC technology‐based regenerative therapy for diabetes
por: Kondo, Yasushi, et al.
Publicado: (2017)

Application of Hepatocyte Growth Factor for Acute Spinal Cord Injury: The Road from Basic Studies to Human Treatment
por: Kitamura, Kazuya, et al.
Publicado: (2019)

A Review of Treatment Methods Focusing on Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation for Chronic Spinal Cord Injury
por: Shibata, Takahiro, et al.
Publicado: (2023)

Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury
por: Okubo, Toshiki, et al.
Publicado: (2016)

Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives
por: Itakura, Go, et al.
Publicado: (2017)

iPSC technology-based regenerative medicine for kidney diseases
por: Osafune, Kenji
Publicado: (2021)

A shift of brain network hub after spinal cord injury
por: Matsubayashi, Kohei, et al.
Publicado: (2023)

Regenerative Rehabilitation and Stem Cell Therapy Targeting Chronic Spinal Cord Injury: A Review of Preclinical Studies
por: Tashiro, Syoichi, et al.
Publicado: (2022)

Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition
por: Nori, Satoshi, et al.
Publicado: (2015)

The prospects of regenerative medicine combined with rehabilitative approaches for chronic spinal cord injury animal models
por: Tashiro, Syoichi, et al.
Publicado: (2017)

Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity
por: Kobayashi, Yoshiomi, et al.
Publicado: (2012)

The adeno-associated virus rh10 vector is an effective gene transfer system for chronic spinal cord injury
por: Hoshino, Yutaka, et al.
Publicado: (2019)

Treadmill Training for Common Marmoset to Strengthen Corticospinal Connections After Thoracic Contusion Spinal Cord Injury
por: Kondo, Takahiro, et al.
Publicado: (2022)

LOTUS Inhibits Neuronal Apoptosis and Promotes Tract Regeneration in Contusive Spinal Cord Injury Model Mice
por: Ito, Shuhei, et al.
Publicado: (2018)

iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021)

Enhanced Functional Recovery from Spinal Cord Injury in Aged Mice after Stem Cell Transplantation through HGF Induction
por: Takano, Morito, et al.
Publicado: (2017)

Assessing cortical plasticity after spinal cord injury by using resting-state functional magnetic resonance imaging in awake adult mice
por: Matsubayashi, Kohei, et al.
Publicado: (2018)

Modeling of Frontotemporal Dementia Using iPSC Technology
por: Kim, Minchul, et al.
Publicado: (2020)

Current progress of rehabilitative strategies in stem cell therapy for spinal cord injury: a review
por: Tashiro, Syoichi, et al.
Publicado: (2021)

Recent progress of iPSC technology in cardiac diseases
por: Funakoshi, Shunsuke, et al.
Publicado: (2021)

Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice
por: Kondo, Takayuki, et al.
Publicado: (2014)

Mending an infarcted heart: The possibility of using iPSC technology
por: Li, Fei
Publicado: (2016)

Long Preservation of AAV-Transduced Fluorescence by a Modified Organic Solvent-Based Clearing Method
por: Lu, Tao, et al.
Publicado: (2022)

Roles of ES Cell-Derived Gliogenic Neural Stem/Progenitor Cells in Functional Recovery after Spinal Cord Injury
por: Kumagai, Gentaro, et al.
Publicado: (2009)

Riluzole as a Neuroprotective Drug for Spinal Cord Injury: From Bench to Bedside
por: Nagoshi, Narihito, et al.
Publicado: (2015)

Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies
por: Rossbach, Bella, et al.
Publicado: (2022)

Clinical Features of Recurrent Spinal Cord Tumors
por: Tsuji, Osahiko, et al.
Publicado: (2022)

Controlling Immune Rejection Is a Fail-Safe System against Potential Tumorigenicity after Human iPSC-Derived Neural Stem Cell Transplantation
por: Itakura, Go, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tmf7tr69o0m1hg4u09a4jc9dd6